Finance

Lists
4016:TADAWUL
Middle East Pharmaceutical Industries Co
62,40 SAR
+1,13%
(+0,70) 1D
15-окт., 15:15:27 GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4016...
Open
61,80 SAR
High
62,50 SAR
Low
61,50 SAR
Mkt. cap
2,18 млд
Avg. vol.
50,58 миң
Volume
44,87 миң
Dividend
2,49%
Quarterly dividend
0,39 SAR
Ex-dividend date
2026-ж., 2-сен.
P/E ratio
20,13
52-wk high
79,10 SAR
52-wk low
53,90 SAR
EPS
3,10 SAR
Shares outstanding
21,55 млн
No. of employees
731
Open
61,80 SAR
High
62,50 SAR
Low
61,50 SAR
Mkt. cap
2,18 млд
Avg. vol.
50,58 миң
Volume
44,87 миң
Dividend
2,49%
Quarterly dividend
0,39 SAR
Ex-dividend date
2026-ж., 2-сен.
P/E ratio
20,13
52-wk high
79,10 SAR
52-wk low
53,90 SAR
EPS
3,10 SAR
Shares outstanding
21,55 млн
No. of employees
731
News stories
From web sources and news partners
About Middle East Pharmaceutical Industries Co
CEOMohamed Maher Al Ghannam
Employees731
Founded1998
HeadquartersЭр-Рияд, Riyadh Province, Сауд Арабиясы
SectorPharmaceutical industry
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
107,95 млн
137,52 млн
130,13 млн
136,48 млн
Cost of goods sold
45,81 млн
47,32 млн
49,78 млн
51,36 млн
Cost of revenue
45,81 млн
47,32 млн
49,78 млн
51,36 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50,78 млн
43,26 млн
48,09 млн
51,16 млн
Operating expense
51,48 млн
43,77 млн
50,05 млн
51,43 млн
Total operating expenses
97,29 млн
91,08 млн
99,83 млн
102,79 млн
Operating income
10,66 млн
46,43 млн
30,30 млн
33,70 млн
Other non operating income
-
-
-
-
EBT including unusual items
9,82 млн
45,93 млн
29,13 млн
30,82 млн
EBT excluding unusual items
9,82 млн
45,89 млн
29,13 млн
30,82 млн
Income tax expense
1,54 млн
1,41 млн
2,23 млн
2,01 млн
Effective tax rate
15,69%
3,07%
7,67%
6,54%
Other operating expenses
-147,78 миң
-109,44 миң
-54,06 миң
-268,26 миң
Net income
8,28 млн
44,52 млн
26,90 млн
28,80 млн
Net profit margin
7,67%
32,38%
20,67%
21,10%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-844,49 миң
-562,26 миң
-1,16 млн
-2,88 млн
Net interest expenses
-844,49 миң
-562,26 миң
-1,16 млн
-2,88 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
13,78 млн
49,70 млн
33,47 млн
37,11 млн
Gain or loss from assets sale
-40,87 миң
-55,44 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору